Join to View Full Profile
2400 Patterson StSte 502Nashville, TN 37203
Phone+1 615-515-1900
Fax+1 615-292-4633
Dr. Horr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2016 - 2018- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2013 - 2016
Duke University HospitalResidency, Internal Medicine, 2010 - 2013
University of Rochester School of Medicine and DentistryClass of 2010
Certifications & Licensure
KY State Medical License 2020 - 2026
TN State Medical License 2018 - 2026
OH State Medical License 2013 - 2018
NC State Medical License 2010 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Trial.Saibal Kar, Raj R Makkar, Brian K Whisenant, Nadira Hamid, Hursh Naik
Circulation. 2025-03-30 - 9 citationsLarge-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Ran...Wissam A Jaber, Carin F Gonsalves, Stefan Stortecky, Samuel Horr, Orestis Pappas
Circulation. 2025-02-04 - 1 citationsCerebral Embolic Protection by Geographic Region: A Post Hoc Analysis of the PROTECTED TAVR Randomized Clinical Trial.Raj R Makkar, Aakriti Gupta, Thomas E Waggoner, Samuel Horr, Juhana Karha
JAMA Cardiology. 2025-01-01
Press Mentions
Akura Enrols First Subject in Pulmonary Embolism Trial of Thrombectomy SystemFebruary 5th, 2025- First Patient Enrolled in Akura Medical's Us Pivotal Trial for Pulmonary EmbolismFebruary 4th, 2025
- Results of SAFE-TAVI Clinical Study Anticipated at TCT 2023October 20th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
